Category: Stock Market

Wait for Bionano Stock to Fall Further Before Buying

Wait for Bionano Stock to Fall Further Before Buying

After months of consolidation, Bionano Genomics (NASDAQ:BNGO) is breaking down. BNGO stock has plummeted 30% since announcing earnings in early November. While the earnings report was decent, some legitimate concerns and a lack of news...

Big Boxes Are Back, and Costco’s a Winner

Big Boxes Are Back, and Costco’s a Winner

An opportunity may be coming to buy Costco Wholesale (NASDAQ:COST) stock. Investors are selling stocks in the biggest retailers, even as they report blowout earnings. If the pattern holds after Costco reports Dec. 9...

The Metaverse Isn’t What You Think

The Metaverse Isn’t What You Think

What’s the first thing that comes to mind when you hear the word “metaverse”? If it’s an immersive virtual reality world that looks like something out of the science fiction movie Ready Player One,...

Progenity Has Too Many Problems, Not Enough Money?

Progenity Has Too Many Problems, Not Enough Money?

In a record blitz of initial public offerings (IPO) like Progenity (NASDAQ:PROG), you’re going to encounter two incontrovertible facts. First, retail investors will have increased opportunities to put their money to work (or at...

Wish Is Bleeding Monthly Users as the World Returns to Normal

Wish Is Bleeding Monthly Users as the World Returns to Normal

ContextLogic (NASDAQ:WISH) operates Wish, an e-commerce platform that facilitates transactions between sellers and buyers, focusing on the budget-conscious consumer. Founded by Piotr Szulczewski and Danny Zhang back in 2010, this company has grown rapidly...

Skillz Stock Is Overvalued After 54% One-Month Run

Skillz Stock Is Overvalued After 54% One-Month Run

Shares of online mobile multiplayer video game competition platform Skillz (NYSE:SKLZ) stock are finally recovering, gaining 54% in the last month. After an excellent debut, the stock struggled and lost a lot of steam....

Progenity: Don’t Bet on This Biotech Firm Yet

Progenity: Don’t Bet on This Biotech Firm Yet

Progenity (NASDAQ:PROG) is a biotech firm focused on treatments and testing products for a variety of diseases. Historically, PROG stock has been a disappointment. Since its initial public offering (IPO) in 2020, shares dropped...

FuboTV Is Still Worth a Long-Term Bet

FuboTV Is Still Worth a Long-Term Bet

Earlier this year, trading shares of New York-based virtual content provider fuboTV (NYSE:FUBO) was a risky proposition. The price action of FUBO stock was like a roller-coaster ride, and not ideal for cautious investors. Source:...

Floki Inu Will Be the Next Shiba Inu, Plain and Simple

Floki Inu Will Be the Next Shiba Inu, Plain and Simple

First, there was the meme token known as Dogecoin (CCC:DOGE-USD). Then came Shiba Inu (CCC:SHIB-USD), which actually managed to overtake Dogecoin in popularity. Yet, there’s a third canine-themed coin, Floki Inu (CCC:FLOKI-USD), and I don’t recommend dismissing...

Sell-the-News Moment Is Your Chance to Reload on Ocugen

Sell-the-News Moment Is Your Chance to Reload on Ocugen

In 2021, biopharmaceutical company Ocugen (NASDAQ:OCGN) has been a paradise for well-timed, short-term traders. On the other hand, long-term OCGN stock investors have been through a virtual roller-coaster ride. Source: shutterstock.com/PhotobyTawat As we’ll see, the...